Physician

Christiane Nwawock Mbianda, M.D.

According to 2025 Medicare claims, Christiane Mbianda, M.D. (NPI: 1255656138) practices nephrology in the South Bend-Mishawaka, IN-MI market, with the plurality of this provider's patient population coming from St. Joseph, IN. This provider's primary affiliated billing organization is NEPHROLOGY PHYSICIANS LLC (NPI: 1518996719; TIN: 352082018) and primary practice location at 46545-3519. Mbianda is affiliated with the CHA ACO, LLC (ACO ID: A2207), Sound Physicians Long Term Care Management, LLC (ACO ID: A5220), Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), and Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Mbianda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 510 traditional Medicare patients, billed 1,971 HCPCS/CPT codes, and received $198,391 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,849 prescription claims across 317 beneficiaries totaling $296,884 in drug costs, led by Xphozah (Tenapanor Hcl). DME data shows 13 claims. Open Payments data shows 38 records totaling $793. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $57,151 and ending at $296,884. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	432	8,053	$134,669
2016	720	15,207	$266,461
2017	922	25,463	$353,416
2018	957	12,122	$313,776
2019	831	9,609	$293,082
2020	651	7,794	$249,648
2021	560	3,317	$238,610
2022	553	2,694	$269,490
2023	499	2,054	$225,937
2024	510	1,971	$198,391

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	111	348	$57,151
2016	243	1,522	$257,848
2017	313	2,356	$476,032
2018	329	2,231	$210,017
2019	342	2,091	$155,291
2020	298	1,999	$124,276
2021	290	1,753	$161,217
2022	312	1,940	$273,009
2023	327	2,075	$328,516
2024	317	1,849	$296,884

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	61	$4,758
2017	N/R	81	$5,421
2018	N/R	22	$386
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	54	$1,566
2022	N/R	23	$412
2023	N/R	N/R	N/R
2024	N/R	13	$188

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	47	195	$264
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	109	132	$121
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	70	165	$87
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	230	476	$62
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	178	553	$57

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xphozah	Tenapanor Hcl	15	450	$45,016
Velphoro	Sucroferric Oxyhydroxide	11	510	$43,703
Auryxia	Ferric Citrate	23	690	$40,897
Kerendia	Finerenone	27	1,360	$29,214
Veltassa	Patiromer Calcium Sorbitex	33	1,748	$26,916

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	13	$188

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	38	$793	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christiane Nwawock Mbianda, M.D.?

Tedicare shows public-source Medicare data for Christiane Nwawock Mbianda, M.D. (NPI 1255656138), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christiane Nwawock Mbianda, M.D. have ACO affiliation data?

Christiane Nwawock Mbianda, M.D. is shown with ACO affiliation data for CHA ACO, LLC (MSSP, ACO ID A2207), Sound Physicians Long Term Care Management, LLC (MSSP, ACO ID A5220), Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403), and Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Christiane Nwawock Mbianda, M.D.?

Christiane Nwawock Mbianda, M.D. is linked to NEPHROLOGY PHYSICIANS LLC (billing NPI 1518996719) in the available physician profile data.

Does Christiane Nwawock Mbianda, M.D. have Open Payments data?

Christiane Nwawock Mbianda, M.D. has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.